Drug intelligence / Profile preview

stomatin-like protein 2

Development stage
Preclinical
Lead developer
Eurac Research
Modality
Gene Therapies
Administration
Intracerebral
01

Overview

Stomatin-like protein 2 (SLP-2), also known as STOML2, is a member of the stomatin family located in the inner mitochondrial membrane. It acts as a mitochondrial scaffold protein that regulates mitochondrial function, integrity, and bioenergetics by organizing cardiolipin-enriched membrane domains and stabilizing mitochondrial respiratory chain complexes. In therapeutic development for Parkinson's disease, SLP-2 is being investigated as a gene therapy target; increasing its expression via viral vectors (such as AAV) has been shown to rescue mitochondrial dysfunction, reduce oxidative stress, and prevent the loss of dopaminergic neurons in models of alpha-synuclein neuropathology.

Other names
STOML2STOML-2STOML 2Stomatin-like protein 2
02

Targets

YME1L1 (YME1-like 1 ATPase)PHB2 (Prohibitin 2)PHB1 (Prohibitin 1)PRKN (E3 ubiquitin-protein ligase parkin)PARL (Presenilin-associated rhomboid-like protein, mitochondrial)SLP-2 (Stomatin-like protein 2, mitochondrial)

Beyond the preview

Go deeper on stomatin-like protein 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on stomatin-like protein 2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call